Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a205
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 156k | $34k | 0% | Dec 2025 |
|
| Geode Capital Management | 156k | $34k | -5% | Dec 2025 |
|
| Citadel Advisors | 144k | $51k | 100% | Sep 2025 |
|
| Jane Street | 122k | $27k | 887% | Dec 2025 |
|
| Northern Trust | 66k | $15k | 100% | Dec 2025 |
|
| Virtu Financial | 64k | $14k | 100% | Dec 2025 |
|
| XTX Topco | 52k | $12k | 100% | Dec 2025 |
|
| Manchester Capital Management | 48k | $11k | 0% | Dec 2025 |
|
| BlackRock | 28k | $6.1k | 0% | Dec 2025 |
|
| Intl Fcstone | 20k | $4.3k | 100% | Dec 2025 |
|
| Two Sigma Securities | 17k | $3.8k | 33% | Dec 2025 |
|
| Susquehanna International | 12k | $2.7k | 100% | Dec 2025 |
|
| Private Management Group | 10k | $2.2k | 0% | Dec 2025 |
|
| UBS Group | 9.2k | $2.0k | -51% | Dec 2025 |
|
| Tower Research Capital | 1.3k | $295.020000 | -2% | Dec 2025 |
|
| SBI Securities | 1.2k | $254.991600 | -17% | Dec 2025 |
|
| Wells Fargo & Company | 160.00 | $35.008000 | 0% | Dec 2025 |
|
| Harbour Investments | 99.00 | $21.997800 | 100% | Dec 2025 |
|
| Abound Wealth Management | 27.00 | $5.999400 | 0% | Dec 2025 |
|
Who sold out of Adial Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hrt Financial | Sep 2025 | 11k | $3.0k |
| Two Sigma Investments | Jun 2025 | 11k | $3.3k |